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Abstract
This study examined the accuracy of self-reported HIV-positive status as an indicator of
entering HIV/AIDS treatment and determined the characteristics and correlates of
receiving regular HIV/AIDS care among people who inject drugs (PWID). Data were
collected through 1,412 personal interviews conducted in the cities of St. Petersburg,
Russia and Kohtla-Järve, Estonia in 2012 and 2013. Overall, in both cities, 81.3% of
PWID were accurately aware of their HIV-positive serostatus; in comparison to
individual level correlates, structural and service utilization variables such as history of
substance abuse treatment and history of incarceration were better determinants of
accurate knowledge of HIV serostatus. We found that 32% of PWID in St. Petersburg
and 73% of PWID in Kohtla-Järve who were aware of their HIV-positive serostatus had
received regular HIV/AIDS care in the past year. Results of this study suggest that
awareness of serostatus alone in this region does not necessarily translate into receiving
HIV/AIDS care and that there is an urgent need for enhancing access to HIV/AIDS care
and treatment among this marginalized population.
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I. Introduction
Eastern Europe has experienced rapid growth in its HIV epidemic since the mid1990s. The HIV epidemic in this region has evolved from approximately 30,000 cases in
1995, which were mostly transmitted through sexual intercourse, to an estimated 1.4
million cases, with PWID accounting for the majority of cases [1]. The rapid increase in
the incidence of HIV/AIDS in Eastern Europe over the past decade has been attributed to
the social and political conditions in the region after the fall of the Soviet Union [2]. The
opening of borders during the reforms of the early 1990s accompanied by increasing
poverty, high unemployment, labor migration, poor health care, and the failure of
political leaders to confront and mitigate these problems have led to the social conditions
that have given rise to expanding injection drug use and ultimately the rapid spread of
HIV [2, 3].
The social and political environment after the dismantling of the Soviet Union and
the region’s current drug use policies have resulted in an HIV epidemic that is
concentrated among PWID with low levels of access to HIV/AIDS treatment and care.
With over 40% of PWID in Eastern Europe being HIV positive and accounting for up to
one-third of new HIV infections, the region is left with a large and growing number of
injection drug users who are in immediate need of HIV/AIDS treatment and care [4-6].
The extent of HIV treatment and care services varies greatly throughout the
region. Although most of the former Soviet Union countries, with the assistance of
international organizations, have taken steps to provide treatment and care services, the
limited data available suggests that access to HIV/AIDS care among this marginalized
population is low [7]. For instance, although access to HIV care and antiretroviral
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treatment (ART) are theoretically universally available in the region, recent studies have
shown that despite the high proportion of HIV cases among PWID, less than 15% of
patients receiving highly active antiretroviral treatment (HAART) are current or former
PWID [8]. Considering the low levels of access to ART, an examination of the steps in
the HIV treatment cascade that occurs prior to the prescription of ART will help
determine the barriers and facilitators of access to ART among this marginalized
population.
The first step in the HIV treatment cascade ensuring that HIV infected individuals
receive an optimal treatment outcome is the test to determine whether they are infected
followed by informing them of their HIV serortatus. Several studies have demonstrated
that once people are aware of their HIV-positive status, they are less likely to participate
in high-risk HIV transmission behaviors and will consequently have a lower risk of
transmitting HIV [9]. In addition to reducing risky behavior and preventing further spread
of infection, knowledge of HIV serostatus is essential for linking the patient to
HIV/AIDS care and treatment [10]. Once an infected individual is aware of their HIV
serostatus, it is important that they become connected with an HIV Health Care provider
who is equipped to provide treatment. Failure to initiate timely HIV care after diagnoses
is associated with greater likelihood of disease progression to AIDS and ongoing
transmission of HIV to others [11]. After knowledge of serostatus, sustained engagement
in HIV care is the next step to receiving successful HIV treatment.
In this report, we examine the accuracy of self-reported HIV-positive status and
access to HIV/AIDS care among PWID in St. Petersburg, Russia and Kohtla-Järve,
Estonia. The Russian Federation and Estonia are two of only three countries in the region
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with an estimated adult HIV prevalence exceeding 1% [8]. Although the region is
beginning to see a shift from IDU to heterosexual HIV transmission, the HIV epidemic in
St. Petersburg and Kohtla-Järve still remains concentrated among PWID which
compromise 1.7% of the population in St. Petersburg and 3.5% of the population in
Kohtla-Järve, for people between the ages of 14-55 [6, 12-15]. The estimated HIV
prevalence among PWID in 2005 was reported to be 90% in Kohtla-Järve and 43% in St.
Petersburg in 2007 [16, 17]. These staggering estimates of HIV prevalence among PWID
in St. Petersburg and Kohtla-Järve are indicators of the large and growing number of
people that are in immediate need of access to HIV/AIDS care.
Limited data are available on the rate of access to HIV/AIDS care in both cities.
Therefore, the objective of this study was to assess the accuracy of self-reported HIVpositive status, as an indicator of entering the HIV/AIDS treatment cascade and
determining the characteristics and correlates of receiving regular HIV/AIDS care among
PWID in the cities of Kohtla-Järve and St. Petersburg.

II. Methods
Study settings, Participants and Procedure
Data for this study were collected through two anonymous cross-sectional studies
of HIV and drug abuse epidemiology, access to prevention and treatment services, and
social psychology research on minority and majority ethnic populations of PWID in
Kohtla-Järve, Estonia and St. Petersburg, Russia. The study in Kohtla-Järve, Estonia was
conducted between May and July of 2012 and recruited a total of 600 current PWID
through the Me Aitame Sind (MAS) syringes exchange project facilities located in
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Kohtla-Järve, Estonia. The study in St. Petersburg, Russia was conducted between
January of 2012 and June of 2013 and recruited a total of 812 current PWID.
Respondent-Driven Sampling (RDS) was used in both cities to recruit current
PWID. Recruitment at both sites began with a non-random selection of “seeds” identified
through venue-based sampling from substance abuse or HIV treatment programs. All
eligible participants were provided with four coupons each to recruit other PWID into the
study and recruitment continued until a predetermined sample size was achieved.
Participants who completed the survey received a primary incentive, a food coupon
equivalent to US$10.00, for participating in the study and a secondary incentive, a food
coupon equivalent to US$5.00 for each recruited participant.
Eligible participants had to be at least 18 years or older, spoke either Russian or
Estonian (in Kohtla-Järve only), reported injection drug use in the last 4 weeks, and were
able to provide informed consent. All participants IDU status was verified by checking
their skin (arms and leg) for injection marks and/or they were asked to explain the
process of preparing drugs for injection.

Measures
Study participants at both sites completed a similar questionnaire administered in
a private setting by trained staff in either Estonian or Russian languages. Data collected
for the interview included demographic and socioeconomic characteristic; IDU network
and recruitment information; contact with drug treatment services and prison; history of
alcohol, tobacco and drug use; HIV risk practices associated with injecting drugs; sexual
behavior, sexual partnerships, history of sex work; knowledge of HIV/AIDS and TB;
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previous HIV testing, reported HIV antibody status and history antiviral treatment; use of
treatment, HIV prevention, social welfare and harm reduction. Participants were also
asked to provide a blood sample for serological testing.
Participants’ self-reported HIV status was obtained. History of HIV care and
treatment was only measured among PWID who self-reported being HIV positive.
Access to HIV care was determined by whether the participant had visited an “HIV
doctor” at least once in the past 12 months. Current and previous use of ART was also
only measured among participants who self-reported HIV positive.
The interview was conducted in approximately 40-60 minutes. After the
interview, all participants were offered pre-test HIV counseling, testing, and appropriate
medical and social service referrals. During the follow-up meeting, each participant was
informed of the results of their HIV test and received post HIV testing counseling.

HIV antibody testing
In Kohtla-Jarve, whole venous blood specimens were collected from all
participants by a trained phlebotomist to detect antibodies to HIV (anti-HIV). Specimens
were screened using commercially available test kits ADVIA Centaur(®) HIV Ag/Ab
Combo assay (Siemens), which have specificities and sensitivities in exccess of 99.5%.
At the post-testing counseling, the participants were provided with information on where
they could receive official testing. The testing was conducted at the Quattromed HTI
laboratory (located in Tallinn, Estonia). In St. Petersburg, on-site oral rapid tests were
used.
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Statistical analysis
For the purpose of this study, PWID who tested HIV-positive by serology
completed as part of the study were categorized into two groups based on their selfreported HIV status. One category included PWID who self-reported HIV-positive and
tested HIV-positive by the serology test. The other group included PWID who selfreported HIV-negative but tested HIV-positive. Those who self-reported HIV negative
include respondents who had never been tested for HIV prior to this study and those who
had been tested but reported not knowing their HIV status (“Inconclusive”, “Did not get
the result”, “don’t know”, and “No answer”).
The sample was described based on their demographic, incarceration history, drug
use behavior, self-reported duration of HIV infection, self-reported latest CD4 count, and
service utilization variables using standard descriptive statistics.
The following correlates were examined to identify factors associated with
accurate knowledge of self-reported HIV-positive serostatus: Demographic; History of
incarceration; Injecting drug use behavior; and access to substance abuse treatment
services. The indicators for injection drug use included the number of years that the
respondent had been injecting drugs and the number of days the respondent reported
injecting drugs, at a minimum, at least once in the past thirty days. The history of
injection drug use was calculated by subtracting the respondent’s age at the time the
study from the age they reported to have injected drugs for the first time for non-medical
purposes. To estimate correlates of accurate knowledge of self-reported HIV-positive
serostatus, logistic regression models and bivariate measure of association were used.
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In addition, among respondents who tested HIV-positive and self-reported HIVpositive, drug use risk behaviors, incarceration history, duration of self-reported HIV
infection, and knowledge of where to receive HIV treatment were assessed for their
relationship with visiting an “HIV doctor” at least once in the past 12 months. To
estimate correlates of accessing HIV care, bivariate and multivariate logistic regression
models were used. Covariates that were associated with the outcome of interest using the
critical value of P<0.2 were included in the initial multivariate model. The final model
was selected using a manual backward elimination procedure, which eliminated all
covariates that did not remain significant at the critical value of P<0.05.
All continuous variables were dichotomized based on a priori meaningful cut
points that have been used by other studies done among similar PWID populations in the
region.

III. Results
A total of 1,412 active PWID were recruited into the study: 812 PWID were
recruited in St. Petersburg and 600 PWID were recruited in Kohtla-Järve. Among the 600
respondents in Kohtla-Järve, a total of 22 participants self-reported HIV positive, but
tested HIV negative during the study. Of the 22 respondents, a total of 12 were excluded
from the study and the remaining 10 were kept in the analysis. The participants excluded
from the analysis had not only reported being HIV+ but also reported receiving HIV care.
The 10 participants that were retained in the study only reported being HIV+ but did not
report being in care. This may be attributed to error in data entry.
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Participant characteristics
Of the 812 injecting drug users recruited in St. Petersburg, a total of 452 (55.7%)
of the participants tested HIV positive by serology at the study visit and are described in
Table 1. Among those retained for analysis (N=452), the majority were Russian (94.5%)
males (79.6%) with an average age of 33.1 years (SD 4.2) who had never married
(51.1%). The majority had completed 9-12 years of education (82.3%). Three-fourths
(75.7%) of the respondents reported having difficulty getting by on their income but only
eight PWID had been homeless in the past six months. The mean duration of injection
drug use was 14.4 years (SD 4.6) and 95.3% reported to have injected drugs every day in
the past thirty days (mean=20.9, SD=7.8). Thirty nine percent reported to have ever been
incarcerated.
Based on the respondents’ self-reported first positive HIV test, 379/452 (83.3%)
of PWID had been aware of their HIV diagnosis for an average of 6.2 years (SD 3.4). The
mean self-reported CD4 count was 346.7 cells/mm3 (SD 239 cells/mm3). The vast
majority of PWID (78.3%) were covered by Russian health insurance. The following is a
list of health care services utilized by this sample: 32.4% had visited a physician for
HIV/AIDS care at least once in the past 12 months; 48.8% had received ART and among
those who had received ART, 74.6% were receiving ART at the time the study was
conducted; 78.8% of the respondents reported to have received substance abuse treatment
and only eleven of those PWID (3.1%) were receiving treatment when recruited into the
study.
Of the total 589 PWID in Kohtla-Järve who were retained in the analysis, 370
(62.8%) tested HIV-positive by serology at the study visit and are described in Table 1.
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This group was predominantly males (73.4%) with a mean age of 30.4 years (SD 4.5).
Approximately half of the respondents had never been married (51.9%) and had
completed less than 9 years of education (50.5%). The vast majority were of Russian
decent (80%) and only 39 (10.6%) of the PWID were of Estonian descent. Ninety-one
percent reported to have a difficult time coping with their income and only 23 (6.2%) had
been homeless in the past six months. Fifty-nine percent of PWID self-reported history of
injection drug use exceeded eleven years (mean=12.2 years, SD=4.7) and 57.7% reported
to have not injected every day in the past 30 days (mean=16.2 days, SD=9.3). Majority of
respondents (63.2%) reported a history of incarceration.
Among the 370 HIV-positive PWID, the self-reported duration of HIV infection
was calculated from the 290 PWID who self-reported an HIV-positive test result. The
mean duration of self-reported HIV-infection was 7.4 years (SD 3.6) and 55.5% reported
an HIV infection less than eight years. The mean of the latest self-reported CD4 count
was 388 cells/mm3 (SD 245 cells/mm3). The following is a list of health care services
utilized by this sample: 73.1% had visited a physician for HIV/AIDS care at least once in
the past 12 months; 82.8% had received ART and among those who had received
treatment, 86.5% were receiving ART at the time the study was conducted; 60.8% of the
respondents reported to have received substance abuse treatment and of those PWID
36.7% were receiving treatment during the course of the study.
Overall, the samples in both cities were similar in terms of age, sex, marital status,
ethnicity, financial status and access to state-provided health insurance. In comparison to
Kohtla-Järve, a greater proportion of the sample in St. Petersburg had completed more
than nine years of education and the history of incarceration was 40% lower. A greater
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proportion in Kohtla-Järve tested HIV-positive by serology at the study visit (63% vs.
56%). Although the mean duration of self-reported HIV infection in St. Petersburg was
shorter, the respondents reported a higher level of injecting risk behavior in comparison
to Kohtla-Järve. The mean number of years of injection drug use in St. Petersburg was
2.2 years greater and three-quarters of the sample in St. Petersburg reported a history of
injection drug use that exceeded eleven years. Also, the frequency of injection drug use in
the past thirty days on average in St. Petersburg was 25% greater than in Kohtla-Järve.
Access to HIV/AIDS related healthcare was higher in Kohtla-Järve. The
proportion of HIV-positive PWID who reported visiting a physician for HIV/AIDS care
was 2.5 times higher in Kohtla-Järve. The proportion of HIV-positive respondents who
reported ever having taken ART was approximately 30% higher in Kohtla-Järve. The
majority of respondents in both cities reported to have received access to substance abuse
treatment services in the past.

Knowledge of HIV-positive status
Among the 812 respondents in St. Petersburg, 760 (93.6%) reported to have been
tested for HIV prior to enrollment in the present study. Of those who had been tested,
383/760 (50.4%) self-reported being HIV positive, 366/760 (48.2%) reported that they
were HIV-negative, and 14/760 (1.8%) didn’t know their status. Ninety percent (531/589)
of the respondents in Kohtla-Järve reported ever having been tested for HIV prior to this
study. Fifty-six percent (299/531) of those who had been tested previously reported to be
HIV positive, 43% (228/531) reported that they were HIV-negative, and 11.5% (61/531)
reported not knowing their HIV status.
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Accuracy of knowledge of HIV-positive serostatus is presented in Figure 1.
Among the 383 PWID in St. Petersburg who self-reported positive serostatus, 100% were
HIV positive by serology test. Of the 427 who self-reported HIV-negative, 69 (16%)
tested HIV-positive and 358 (84%) accurately reported their HIV-negative status. In
Kohtla-Järve, among the 299 who self-reported positive serostatus, 289(97%) were HIVpositive by serology test. Of the 228 who self-reported HIV-negative, 81 (36%) tested
HIV-positive by the serology test and 208 (91%) accurately reported their HIV-negative
status. Overall, a higher proportion (85% vs. 78%) of respondent in St. Petersburg had
accurate knowledge of their HIV-positive status.

Correlates of accurate knowledge of HIV status
As indicated in Table 2, correlates of accurately reporting HIV-positive status
were measured using bivariate analysis. In St. Petersburg, among the 452 respondents
with HIV-positive serostatus, in the unadjusted analysis, Russian ethnicity (OR 4.16,
95% CI 1.78-9.69), history of IDU exceeding eleven years (OR 2.66, 95% CI 1.56-4.55),
history of receiving substance abuse treatment (OR 2.70, 95% CI 1.56-4.69), and
financial hardship (OR 1.85, 95% CI 1.07-3.21) were associated with accurate knowledge
of HIV-positive status. Among the 370 PWID in Kohtla-Järve who tested HIV-positive
by serology test, in the unadjusted analysis, age exceeding 30 years (OR 1.88, 95% CI
1.13-3.13), history of incarceration (OR 4.38, 95% CI 2.60-7.36), IDU history exceeding
eleven years (OR 2.16, 95% CI 1.31-3.55), financial hardship (OR 2.20, 95% CI 1.034.68), and history of receiving substance abuse treatment (OR 4.35, 95% CI 2.58-7.35)
were all associated with accurate knowledge of the respondents HIV-status.
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As indicated in Table 2 (far right column), in the adjusted analysis of the St.
Petersburg study, Russian ethnicity (OR 3.95, 95% CI 1.62-9.66), history of IDU
exceeding eleven years (OR 2.50, 95% CI 1.44-4.36), and ever receiving substance abuse
treatment (OR 2.54, 95% CI 1.43-4.50) remained significantly associated with accurate
knowledge of self-reported HIV-positive status. In the adjusted analysis of the KohtlaJärve study, history of incarceration (OR 3.28, 95% CI 1.90-5.66) and having ever
received substance abuse treatment (OR 3.20, 95% CI 1.44-5.53) remained significantly
associated with the outcome of interest.

Correlates of visiting a physician for HIV/AIDS care
Correlates of visiting a physician for HIV/AIDS care at least once in the past 12
months among PWID in St. Petersburg who tested HIV positive and self-reported HIVpositive is described in Table 3. Among the 383 PWID who were analyzed for the
outcome of interest, in the unadjusted analysis, completing over 12 years of education
(OR 2.92, 95% CI 1.03-8.27), having health insurance (OR 1.84, 95% CI 1.03-3.26),
financial hardship (OR 0.52, 95% CI 0.32-0.86), duration of HIV infection exceeding
eight years (OR 2.40, 95% CI 1.46-3.92), knowledge of where to receive HIV treatment
(OR 1.93, 95% CI 0.21-17.44) were all significantly correlated with receiving HIV/AIDS
care.
Among the PWID in Kohtla-Järve who tested HIV-positive and self-reported
HIV-positive, the following correlates were all significantly correlated with the outcome
of interest: Male (OR 0.46, 95% CI 1.46-3.92), Russian ethnicity (OR 1.92, 95% CI 1.013.61), having health insurance (OR 8.62, 95% CI 4.31-17.25), HIV infection that
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exceeded eight years (OR 2.37, 95% CI 1.36-4.13), and knowledge of where to receive
HIV care (OR 8.71, 95% CI 1.72-44.10).
In the adjusted analysis, at both sites, having state-issued health insurance (St.
Petersburg: OR 1.93, 95% CI 1.06-3.50, Kohtla-Järve: OR 8.92, 95% CI 4.21-18.9) and
HIV infection exceeding eight years (St. Petersburg: OR 2.49, 95% CI 1.51-4.13, KohtlaJärve: OR 2.19, 95% CI 1.18-4.07) remained significantly associated with visiting an
“HIV doctor” at least once in the past 12 months. In St. Petersburg alone, in the adjusted
analysis, financial hardship (OR 0.47, 95% CI 0.28-0.80) also remained significantly
correlated with receiving HIV/AIDS care. In Kohtla-Järve, in addition to the
aforementioned covariates, sex (OR 0.33, 95% CI 0.15-0.73) and knowledge of where to
receive HIV care (OR 2.0, 95% CI 1.30-42.6) remained statistically significant.

IV. Discussion
Our findings suggest that the majority of the PWID sample population in St.
Petersburg (94%) and Kohtla-Järve (90%) had been tested for HIV prior to this study. An
examination of the accuracy of the participant’s self-reported HIV- positive serostatus
revealed that a higher proportion of respondents in St. Petersburg (85% vs. 78%) had
accurate knowledge of their HIV-positive status. However, we found that only a small
proportion (32%) of HIV-positive PWID aware of their serostatus had received
HIV/AIDS care in St. Petersburg. In order to better understand the differences in
HIV/AIDS care and treatment among the PWID population in St. Petersburg and KohtlaJärve, we examined various individual and structural level correlates of accurate
knowledge of HIV status and access to HIV/AIDS care.
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Our analysis of individual and structural-level correlates of accurate knowledge of
HIV-positive serostatus revealed several significant relationships. Of the individual level
correlates we analyzed, in St. Petersburg, Russian ethnicity and history of injection drug
use exceeding eleven years were associated with greater likelihood of having accurate
knowledge of HIV-positive serostatus. Among the structural-level variables, in both
cities, history of receiving substance abuse treatment and in Kohtla-Järve, history of
incarceration were associated with greater likelihood of accurate knowledge of HIVpositive serostatus. The aforementioned covariates – incarceration and entering substance
abuse treatment - that we found to be statistically significant are all events that provide
contact with settings that require HIV testing. Therefore, it is possible that, in comparison
to individual-level correlates, structural and service utilization variables are better
determinants of accurate knowledge of HIV status. These findings also suggest that
policies aimed at increasing the rate of HIV testing in prison settings and through harm
reduction services are reaching many more in this marginalized population.
Our findings suggest that awareness of serostatus alone does not necessarily
translate into receiving HIV/AIDS care. We found that 32% of PWID in St. Petersburg
and 73% of PWID’s in Kohtla-Järve who were aware of their HIV-positive serostatus had
visited an “HIV doctor” at least once in the past 12 months. Several important individual
and structural-level factors emerged in our analysis as correlates of access to HIV/AIDS
care. First, in both cities, PWID aware of their HIV-positive serostatus, who had stateissued health insurance, and self-reported to had been infected with HIV for greater than
eight years were significantly more likely to be receiving HIV/AIDS care. This finding
suggests that in both cities PWID who had been recently infected and were aware of their
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HIV-positive status were not receiving HIV/AIDS treatment and care. Several other
studies have reported similar findings on PWID receiving treatment and care later in the
course of HIV infection and often after the disease has progressed to AIDS [5, 18]. There
are several plausible explanations for the late presentation of PWID for HIV/AIDS
treatment and care. For instance, any of the following “socio-political” barriers: social
marginalization; risk of criminal sanctions; incarceration; or financial barrier may have
played a role in the lack of access to treatment and care among this marginalized
population [5, 19, 20]. Our findings revealed that PWID in St. Petersburg who reported
experiencing financial difficulties were less likely to have visited an “HIV doctor” in the
past 12 months. An additional explanation for the lack of access to treatment might be
explained by the lack of post HIV-testing counseling and/or the lack of referrals to
HIV/AIDS treatment and care providers. Further research is needed to fully understand
the barriers to HIV/AIDS care among this marginalized population in St. Petersburg and
Kohtla-Järve.
This study has several limitations that need to be addressed. First, our findings
may be affected by the limitations that apply to using self-reported measures of drug
abuse behaviors and HIV testing histories. Participants might tend to avoid reporting
what they perceive interviewers will judge as socially improper responses on sensitive
issues, such as drug abuse behaviors, and provide responses that are more socially
desirable [21] . Also, the participants’ duration of HIV infection was calculated from
their self-reported HIV testing history and therefor might be subject to unintentional
inaccurate reporting due to recall bias [10]. Despite these potential limitations, these
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results present the first measurement of access to HIV/AIDS care and treatment among
PWID in St. Petersburg, Russia and Kohtla-Järve, Estonia.
The findings of this study have significant policy implications, suggesting an
urgent need for enhancing access to HIV/AIDS care and treatment among this
marginalized population. Our data revealed sub-optimal coverage of HIV/AIDS care
especially among the recently infected IDU population in St. Petersburg, Russia. Further
research is needed to investigate the lack of utilization of HIV/AIDS care, in both cities,
especially among those who have been recently been infected with HIV.
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Appendix
Figure 1 Classification of PWID by HIV serology test results and self-reported HIV status
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Table 1 - Characteristics of PWID who tested HIV-positive
Characteristic
Age (years), mean ± SD
Sex
Male
Female
Education
≤ 9 yrs
9-12 yrs
>12 yrs
Marital status
Married/common law
Widowed
Divorced
Never Married
Ethnicity
Russian
Estonian
Other
Health insurance
Yes
No
Currently coping with income
Yes
No
Homeless in the past 6 months
Yes
No
Ever been in prison or jail
Yes
No
History of Injection drug use
≤11 yrs
>11 yrs
Frequency of IDU in past 30 days
<30 days
≤30 days
Ever received substance abuse treatment
Yes
No
Currently receiving substance abuse treatment
Yes
No
Received HIV care at least once in the past 12 months
Yes
No
Duration of HIV infection
≤ 8 yrs
>8 yrs
Latest CD4 count (cells/mm3)
<350
≥350

St. Petersburg
n=452(%)*
33.1±4.2

Kohtla-Järve
n=370 (%)*
30.4±4.5

360/452(79.6)
92/452(20.3)

271/369(73.4)
98/369 (26.5)

40/452(8.8)
372/452(82.3)
40/452(8.8)

187/370(50.5)
183/370 (49.5)
0(0)

135/452(29.9)
2/452(0.4)
84/452(18.6)
231/452(51.1)

145/370 (39.2)
7/370 (1.9)
26/370 (7.0)
192/370 (51.9)

427/452(94.5)
0/452(0)
25/452(5.5)

299/369 (80.0)
39/369 (10.6)
31/369 (8.4)

354/452(78.3)
97/452(21.5)

306/370 (82.7)
64/370 (17.3)

109/449(24.3)
340/449(75.7)

33/367(9.0)
334/367 (91.0)

8/452(1.8)
444/452(98.2)

23/370 (6.2)
347/370 (93.8)

176/452(38.9)
276/452(61.1)

234/370 (63.2)
136/370 (36.8)

111/452(24.6)
341/452(75.4)
Mean=14.4, SD=4.6

151/370 (40.8)
219/370 (59.2)
Mean=12.2, SD=4.7

21/452(4.6)
431/452(95.3)
Mean=20.9, SD=7.8

346/369 (93.8)
24/369 (6.5)
Mean=16.2, SD=9.3

356/452 (78.8)
96/452 (21.2)

225/370 (60.8)
145/370 (39.2)

11/356(3.1)
345/356(96.9)

83/226(36.7)
143/226(63.3)

125/386 (32.4)
261/386 (67.6)

212/290(73.1)
78/290(2.7)

290/379(76.5)
89/379(23.5)
Mean=6.2, SD=3.4

161/290(55.5)
129/290(44.5)
Mean=7.4, SD=3.6

75/207(36.2)
132/207(63.8)
Mean=346.7,SD=239.1

74/154(48.0)
80/154(51.9)
Mean=387.7, SD=245.3

Ever taken any antiretroviral therapy
Yes
63/129(48.8)
139/169(82.2)
No
66/129(51.2)
29/169 (17.2)
Currently receiving antiretroviral therapy
Yes
47/63(74.6)
122/141(86.5)
No
16/63(25.4)
19/141(13.5)
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding.

22

Table 2 - Correlates of self-reported HIV-positive status among PWID in St. Petersburg who tested HIV+
Characteristic
Age (years)
≤30
>30
Sex
Male
Female
Education
≤ 9 yrs
9-12 yrs
>12 yrs
Marital status
Married/common law
Divorced or widowed
Never married
Ethnicity
Russian
Other
Health insurance
Yes
No
Currently coping with income
Yes
No
Ever been in prison or jail
Yes
No
History of Injection drug use
≤11 yrs
>11 yrs
Frequency of IDUPWID in past
30 days
<30 days
≥30 days
Ever received substance abuse
treatment
Yes
No

HIV+ Serostatus (n=452)
SR- (n=69)
SR+ (n=383)
25(36.2)
44(63.8)

uOR

95% CI

110(28.7)
273(71.3)

Referent
1.41

(0.82-2.42)

58(84.1)
11(15.9)

302(78.8)
81(21.1)

0.71
Referent

(0.35-1.41)

4(5.8)
58(84.1)
7(10.1)

36(92.3)
314(82.0)
33(8.6)

Referent
0.60
0.52

19(27.5)
9(12.8)
41(59.4)

116(30.3)
77(20.1)
190(49.6)

0.71
Referent
0.54

(0.31-1.66)

59(85.5)
10(14.5)

368(96.1)
15(3.9)

4.16
Referent

(1.78-9.69)

52(75.4)
17(24.6)

302(78.8)
80(20.1)

1.23
Referent

(0.68-2.25)

24(34.8)
45(65.2)

85(22.4)
295(77.6)

Referent
1.85

20(29.0)
49(71.0)

156(40.7)
227(59.3)

1.68
Referent

29(42.0)
40(58.0)

82(21.4)
301(78.6)

Referent
2.66

4(5.8)
65(94.2)

17(4.4)
366(95.6)

1.32
Referent

(0.43-4.06)

43(62.3)
26(37.7)

313(81.7)
70(18.3)

2.70
Referent

(1.56-4.69)

aOR

95% CI

(0.21-1.75)
(0.14-1.95)

(0.25-1.17)
3.95
Referent

(1.62-9.66)

(1.07-3.21)
(0.96-2.94)

(1.56-4.55)

* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding.

Referent
2.50

2.54
Referent

(1.44-4.36)

(1.43-4.50)
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Table 2 - Correlates of self-reported HIV-positive status among PWID in Kohtla-Järve who tested HIV+
Characteristic
Age (years)
≤30
>30
Sex
Male
Female
Education
≤ 9 yrs
9-12 yrs
>12 yrs
Marital status
Married/common law
Divorced or widowed
Never married
Ethnicity
Russian
Other
Health insurance
Yes
No
Currently coping with income
Yes
No
Ever been in prison or jail
Yes
No
History of Injection drug use
≤11 yrs
>11 yrs
Frequency of IDU in past 30 days

HIV+ Serostatus (n=370)
SR- (n=81)
SR+ (n=289)

uOR

95% CI

52(64.2)
29(35.8)

141(48.8)
148(51.2)

Referent
1.88

60(74.1)
21(25.9)

211(73.3)
77(26.7)

0.96
Referent

(0.55-1.68)

38(46.9)
43(53.1)
0(0)

149(51.6)
140(48.4)
0(0)

Referent
0.83

(0.51-1.36)

41(50.6)
4(4.9)
36(44.4)

104(36.0)
29(10.0)
156(54.0)

0.60
Referent
0.35

(0.20-1.81)

63(77.8)
18(22.2)

236(81.9)
52(18.1)

1.30
Referent

(0.71-2.37)

63(77.8)
18(22.2)

243(84.1)
46(15.9)

1.51
Referent

(0.82-2.78)

12(14.8)
69(85.2)

21(7.3)
265(92.7)

Referent
2.20

29(35.8)
52(64.2)

205(70.9)
84(29.1)

4.38
Referent

45(55.6)
36(44.4)

106(36.7)
183(63.3)

Referent
2.16

aOR

95% CI

(1.13-3.13)

(0.12-1.06)

(1.03-4.68)
(2.60-7.36)

3.28
Referent

(1.90-5.66)

3.20
Referent

(1.84-5.53)

(1.31-3.55)

<30 days
0(0)
265(91.7)
≥30 days
81(100.0)
24(8.3)
Ever received substance abuse
treatment
Yes
27(33.3)
198(68.5)
4.35
(2.58-7.35)
No
54(66.7)
91(31.5)
Referent
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding.
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Table 3 - Correlates of receiving HIV care at least once every 12 months among PWID who self-reported HIV positive and
serotested HIV-positive
Characteristic

St. Petersburg (N=383)
No (n=259)
Yes (n=124)

uOR

95% CI

Age (years)
≤30
76(29.3)
34(27.4)
Referent
>30
183(70.7)
90(72.6)
1.10
(0.68-1.77)
Sex
Male
209(80.7)
93(75.0)
0.72
Female
50(19.3)
31(25.0)
Referent
(0.43-1.20)
Education
≤ 9 yrs
28(10.8)
8(6.4)
Referent
9-12 yrs
213(82.2)
101(81.4)
1.66
(0.73-3.77)
>12 yrs
18(6.9)
15(12.1)
2.92
(1.03-8.27)
Marital status
Married/common law
83(32.0)
33(26.6)
0.88
(0.47-1.65)
Divorced or widowed
53(20.5)
24(19.3)
Referent
Never married
123(47.5)
67(54.0)
1.20
(0.68-2.12)
Ethnicity
Russian
249(96.1)
119(96.0)
0.96
(0.32-2.86)
Other
10(3.9)
5(4.0)
Referent
Health insurance
Yes
197(76.1)
105(84.7)
1.84
(1.03-3.26)
No
62(23.9)
18(14.5)
Referent
Currently coping with income
Yes
48(18.6)
37(30.3)
Referent
No
210(81.4)
85(69.7)
0.52
(0.32-0.86)
Ever been in prison or jail
Yes
107(41.3)
49(39.5)
0.93
(0.60-1.44)
No
152(58.6)
75(60.5)
Referent
History of Injection drug use
≤11 yrs
60(23.2)
22(17.7)
Referent
>11 yrs
199(76.8)
102(82.3)
1.40
(0.81-2.41)
Frequency of IDU in past 30 days
<30 days
62(23.9)
45(36.3)
1.16
≥30 days
197(76.1)
79(63.7)
Referent
(0.40-3.36)
Ever received substance abuse
treatment
Yes
212(81.8)
23(18.5)
0.97
(0.56-1.69)
No
47(18.1)
101(81.4)
Referent
Duration of HIV disease
≤8 yrs
208(82.2)
81(65.9)
Referent
>8 yrs
45(17.8)
42(34.1)
2.40
(1.46-3.92)
Do you know where you can
get HIV treatment
No
4(1.6)
1(0.8)
Referent
Yes
255(98.5)
123(99.2)
1.93
(0.21-17.44)
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding.

AOR

95% CI

1.93
Referent

(1.06-3.50)

Referent
0.47

(0.28-0.80)

Referent
2.49

(1.51-4.13)
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Table 3 - Correlates of receiving HIV care at least once every 12 months among PWID who self-reported HIV positive and
serotested HIV-positive
Characteristic
Age (years)
≤30
>30

Kohtla-Järve (N=289)
No (n=78)
Yes (n=211)

uOR

95% CI

39(50.0)
39(50.0)

102(48.3)
109(51.7)

Referent
1.07

(0.63-1.80)

Male

65(83.3)

146(69.5)

0.46

(0.23-0.89)

Female

13(16.7)

64(30.5)

Referent

42(53.8)
36(25.7)
0(0.0)

107(50.7)
104(49.3)
0(0.0)

1.13
Referent

(0.67-1.91)

Married/common law

24(30.8)

80(37.9)

1.75

(0.72-4.28)

Divorced or widowed

10(12.8)

19(9.0)

Referent

Never married

44(56.4)

112(53.1)

1.34

(0.58-3.12)

Russian

58(74.4)

178(84.8)

1.92

(1.02-3.61)

Other

20(25.6)

32(15.2)

Referent

AOR

95%CI

Sex

Education
≤ 9 yrs
9-12 yrs
>12 yrs

0.33

(0.15-0.73)

Referent

Marital status

Ethnicity

Health insurance
Yes
No
Currently coping with income
Yes
No

47(60.3)
31(39.7)

196(92.9)
15(7.1)

8.62
Referent

5(6.5)
72(93.5)

16(92.3)
193(92.3)

Referent
0.84

59(75.6)
19(24.4)

146(69.2)
65(30.8)

0.72
Referent

(4.31-17.25)

8.92
Referent

(4.21-18.9)

(0.30-2.37)

Ever been in prison or jail
Yes
No

(0.40-1.31)

History of Injection drug use
≤11 yrs
31(39.7)
75(35.5)
Referent
>11 yrs
47(60.3)
136(64.4)
1.20
(0.70-2.04)
Frequency of IDU in past 30
days
<30 days
71(91.0)
194(91.9)
Referent
≥30 days
7(9.0)
17(8.1)
0.89
(0.35-2.23)
Ever received substance abuse
treatment
Yes
25(32.0)
66(31.3)
1.04
(0.59-1.81)
No
53(67.9)
145(68.7)
Referent
Duration of HIV infection
≤8 yrs
55(70.5)
106(50.2)
Referent
Referent
>8 yrs
23(29.5)
105(49.8)
2.37
(1.36-4.13)
2.19
Do you know where you can
get HIV treatment
Yes
72(92.3)
209(99.0)
8.71
(1.72-44.10)
2.0
No
6(7.7)
2(0.9)
Referent
Referent
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding.

(1.18-4.07)

(1.30-42.6)
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